TNGX (TNGX) Stock Price & Analysis
TNGX (TNGX) fell 1.05% to USD 22.52 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
TNGX last closed at USD 22.52; the session ranged USD 22.29–22.94 on volume of 1,457,380 shares. Market capitalization is —, with a 52-week range of USD 6.25–34.39 (NGM). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 22.52 |
|---|---|
| Change | ▼ 1.05% (down) |
| Previous Close | USD 22.52 |
| Open | USD 22.52 |
| Day Range | USD 22.29 – 22.94 |
| 52-Week Range | USD 6.25 – 34.39 |
| Volume | 1,457,380 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TNGX)
Nexqual's technical model rates TNGX "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.96 (neutral) |
| vs SMA50 | Below (USD 27.09) |
| MACD | -1.24 (negative) |
From TNGX's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ERAS | Erasca, Inc. | USD 16.19 | ▼ 1.1% |
| GLUE | Monte Rosa Therapeutics, Inc. | USD 13.84 | ▼ 2.67% |
| TYRA | Tyra Biosciences, Inc. | USD 28.65 | ▲ 14.01% |
| RLAY | Relay Therapeutics, Inc. | USD 19.04 | ▲ 2.86% |
| TVTX | Travere Therapeutics, Inc. | USD 65.28 | ▼ 2.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.